Personal profile
Education
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 2 Finished
-
Using Lung Cancer Patient-Derived Xenograft (Pdx) to Explore the Interaction between Yap Signaling Pathway and Cyclin-Dependent Kinases (Cdk) and New Therapeutic Target for Lung Cancer
Hsu, P.-C. (PI)
01/08/23 → 31/07/24
Project: National Science and Technology Council › National Science and Technology Council Academic Grants
-
The Role of Yes-Associated Protein (Yap) and Cyclin-Dependent Kinase 9 (Cdk9) in Regulating Lung Cancer Brain Metastasis and Application of Lung Cancer Patient-Derived Xenograft (Pdx) Mice Model to Develop Novel Treatment (To Continue 2019 Most).( III )
Hsu, P.-C. (PI)
01/08/22 → 31/07/23
Project: National Science and Technology Council › National Science and Technology Council Academic Grants
-
Dacomitinib as a First-Line Therapy for Advanced EGFR-Mutated Non-Small Cell Lung Cancer Without Brain Metastases: A Multicenter Retrospective Observational Study
Hsu, P. C., Ko, H. W., Chiu, L. C., Huang, S. H., Lee, C. S., Lin, Y. C., Kuo, S. C. H., Ju, J. S., Wang, C. C. & Yang, C. T., 03 2026, In: Cancer Medicine. 15, 3, p. e71659 e71659.Research output: Contribution to journal › Journal Article › peer-review
Open Access -
Flavones and Aminoflavones Increase the Cytotoxicity of NK Cells in Human Non-Small Cell Lung Cancer
Hsu, P. C., Chien, C. C., Cheng, Y. J., Chang, C. H. & Shih, T. L., 02 2026, In: Journal of Cellular and Molecular Medicine. 30, 4, p. e71055 e71055.Research output: Contribution to journal › Journal Article › peer-review
Open Access -
Analysis of genomic alternations in epidermal growth factor receptor (EGFR)-T790M-mutated non-small cell lung cancer (NSCLC) patients with acquired resistance to osimertinib therapy
Hsu, P. C., Chang, J. W. C., Chiu, L. C., Yang, C. T., Kuo, S. C., Fang, Y. F. & Wu, C. E., 05 2025, In: Clinical and Translational Oncology. 27, 5, p. 1967-1979 13 p., 100007.Research output: Contribution to journal › Journal Article › peer-review
Open Access2 Scopus citations -
Baseline and changes in inflammatory parameters for patients with EGFR-mutated NSCLC treated with afatinib
Chang, Z. T., Hsu, P. C., Ko, H. W., Chang, J. W. C., Wu, C. T., Huang, C. Y., Chang, C. F., Kuo, C. H. S., Yang, C. T. & Wu, C. E., 07 2025, In: Thoracic Cancer. 16, 13, p. e15338 e15338.Research output: Contribution to journal › Journal Article › peer-review
Open Access -
Clinical outcome analysis of different first- and second-generation EGFR-tyrosine kinase inhibitors in untreated patients with EGFR-mutated non-small cell lung cancer with baseline brain metastasis
Hsu, C. C., Chiu, L. C., Ko, H. W., Wu, C. E., Kuo, S. C. H., Ju, J. S., Huang, A. C. C., Wang, C. C., Yang, C. T. & Hsu, P. C., 04 2025, In: Oncology Letters. 29, 4, p. 201 201.Research output: Contribution to journal › Journal Article › peer-review
Open Access2 Scopus citations